On Thursday, China began enrolling patients in a clinical trial of remdesivir, an antiviral medicine made by Gilead, the US pharmaceutical giant. The drug has to be given intravenously, is experimental and not yet approved for any use, and has not been studied in patients with any coronavirus disease. Personnel from the health ministry participate in a drill to prepare for the potential arrival of passengers infected with the coronavirus at the Viru Viru International Airport, in Santa Cruz, Bolivia, Feb 6, 2020. Two clinical trials will take place in Wuhan, China, the centre of the outbreak; 500 patients will receive the drug, and comparison groups will get a placebo, McKeel said. Personnel from the health ministry participate in a drill to prepare for the potential arrival of passengers infected with the coronavirus at the Viru Viru International Airport, in Santa Cruz, Bolivia, Feb 6, 2020.

Source: bd News24 February 07, 2020 06:56 UTC